Skip to content

Incidence of Hypotension in the Post-anesthesia Care Unit (PACU).

Incidence of Hypotension in the Post-anesthesia Care Unit (PACU).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07022210
Enrollment
100
Registered
2025-06-15
Start date
2025-06-15
Completion date
2026-05-01
Last updated
2025-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension During Surgery, Surgery-Complications

Keywords

hypotension, post-anesthesia care unit, surgery, adult

Brief summary

The perioperative period poses a heightened risk of complications for patients, including hypotension. While the issue of intraoperative hypotension is well-documented in medical literature, the occurrence and causes of hypotension in the post-anesthesia care unit often receive less attention. This phase of postoperative care, however, is vital for ensuring patient stability and preventing severe consequences. Failure to identify and manage a drop in blood pressure can lead to hypoperfusion of critical organs, increasing the risk of morbidity and mortality. The aim of this study is to examine the frequency of hypotension in the post-anesthesia care unit-defined as systolic blood pressure \<90 mmHg or a drop of more than 20% from baseline-and to identify factors contributing to its development.

Detailed description

The perioperative period is a critical time for patients, marked by an increased risk of various complications, including hypotension. While intraoperative hypotension is extensively studied in medical literature, the occurrence and underlying causes of hypotension in the post-anesthesia care unit (PACU) often remain overlooked. This phase of postoperative care is essential for stabilizing the patient and preventing severe outcomes. A failure to identify and adequately address a drop in blood pressure during this time can result in hypoperfusion of vital organs, increasing the likelihood of morbidity and mortality. Hypotension in the PACU is defined as a systolic blood pressure below 90 mmHg or a decrease exceeding 20% compared to the patient's baseline measurements. The aim of this research is to explore the prevalence of hypotension in the PACU and to analyze the factors contributing to its occurrence. By improving the understanding of this issue, the study seeks to enhance patient outcomes through timely identification and management of hypotension in this crucial phase of care.

Interventions

None listed

Sponsors

Tomas Bata Hospital, Czech Republic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 105 Years
Healthy volunteers
Yes

Inclusion criteria

* patients over 18 years old * patients undergoing a procedure under general anesthesia * patients who have consented to data processing * postoperative stay in PACU

Exclusion criteria

* patients younger than 18 years old. * patients transferred directly to the ICU/Anesthesiology and Resuscitation Department after surgery without staying in the recovery room. * patients with incomplete medical documentation or missing blood pressure values in the recovery room. * patients with a pre-existing diagnosis of resistant hypotension or unstable hemodynamics before surgery * patients with a history of long-term use of anxiolytics, antipsychotics, or other psychotropic medications that may affect cognitive function, emotional state, or predictive outcomes * patient refusal to participate in the study (including cases where they initially consented), with an emphasis on respecting patient autonomy

Design outcomes

Primary

MeasureTime frameDescription
Incidence of hypotension in the post-anesthesia care unit (PACU).0. postoperative dayHypotension is defined as systolic blood pressure \<90 mmHg or a decrease of more than 20% from baseline values.

Secondary

MeasureTime frameDescription
Duration of the operation0. postoperative dayDuration of the surgical procedure as a risk factor for the development of postoperative hypotension. The duration will be recorded in minutes.
ASA classification (American Society of Anesthesiologists classification).0. postoperative dayASA classification as a risk factor for the development of postoperative hypotension. ASA I: A normal healthy patient with no systemic disease. ASA II: A patient with mild systemic disease that does not limit daily activities (e.g., well-controlled diabetes or hypertension). ASA III: A patient with severe systemic disease that limits daily activities but is not incapacitating (e.g., poorly controlled diabetes or hypertension, chronic obstructive pulmonary disease). ASA IV: A patient with severe systemic disease that is a constant threat to life (e.g., unstable angina, symptomatic heart failure). ASA V: A moribund patient who is not expected to survive without surgery (e.g., ruptured abdominal aneurysm).
Type of anesthesia.0. postoperative dayThe type of anesthesia used: general, regional, and/or peripheral nerve block.
Blood loss during the operation0. postoperative dayBlood loss during the surgical procedure, as documented in the surgical protocol.
Fluid balance during the surgery0. postoperative dayFluid intake and output during surgery, measured in milliliters.
Surgical specialty0. postoperative daySurgical specialties: neurosurgery, urology, gynecology, abdominal surgery, orthopedics
Fluid administration in the recovery room.0. postoperative dayAdministration of a crystalloid or colloid bolus to augment intravascular volume.
Blood pressure monitoring.0. postoperative dayRepeated blood pressure measurement every 5 minutes.
Administration of vasopressors.0. postoperative dayIn cases of severe hypotension, vasopressor administration (e.g., ephedrine, phenylephrine, norepinephrine) may be required to ensure adequate perfusion of vital organs.
Patient repositioning0. postoperative dayThe Trendelenburg position (legs elevated above the head) can help increase venous return and consequently blood pressure. It will not be performed in surgeries involving the lower extremities.
Transfer of the patient to the ICU due to hemodynamic instability0. postoperative dayIf hypotension does not improve despite repeated therapeutic interventions, escalation of care to the ICU may be necessary.
Postoperative nausea and vomiting0. postoperative dayInadequate gastrointestinal perfusion can lead to nausea and vomiting, complicating the patient's recovery.
Impaired diuresis (oliguria, anuria)0. postoperative dayOliguria is a medical term referring to low urine output, typically defined as producing less than 400-500 mL of urine per day in adults. Anuria is a medical condition characterized by the absence or near absence of urine production, typically defined as less than 100 mL of urine per day.
Impaired consciousness - GCS0. postoperative dayThe Glasgow Coma Scale (GCS) is a clinical tool used to assess a person's level of consciousness after a brain injury. It evaluates three responses: eye opening, verbal response, and motor response, with scores ranging from 3 (deep coma) to 15 (fully alert).
Hypoxia0. postoperative dayWill be assessed using oxygen saturation levels (SpO₂). Mild hypoxia: SpO₂ 90-94% Moderate hypoxia:r SpO₂ 75-89% Severe hypoxia: SpO₂ \<75%
Lactic acidosis0. postoperative dayLactic acidosis is a condition characterized by the accumulation of lactic acid in the bloodstream, leading to a decrease in blood pH. It can result from tissue hypoxia, impaired metabolism, or certain medical conditions. Lactic acidosis is generally defined by a serum lactate concentration above 4 mmol/L. Mild elevations in lactate (hyperlactatemia) occur at levels above 2 mmol/L, but true lactic acidosis is diagnosed when lactate levels exceed 4 mmol/L
Syncope0. postoperative daySyncope is a temporary loss of consciousness due to a sudden decrease in blood flow to the brain. It typically has a rapid onset, short duration, and spontaneous recovery
Heart rate monitoring.0. postoperative dayContinuous heart rate monitoring.

Countries

Czechia

Contacts

Primary ContactKlára Nekvindová, M.D., P.h.D.
nekvindova.klara@gmail.com+420 577 551 111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026